ReviewFrontiers in cell and developmental biology2022

Plasmalogenic Lipid Analogs as Platelet-Activating Factor Antagonists: A Potential Novel Class of Anti-inflammatory Compounds.

Pu Rong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.